Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Frank Scott

Concepts (298)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Bowel Diseases
24
2025
326
7.870
 Why?
Crohn Disease
13
2022
217
4.230
 Why?
Colitis, Ulcerative
8
2024
120
2.020
 Why?
Gastrointestinal Agents
5
2024
60
1.660
 Why?
Infliximab
10
2022
101
1.630
 Why?
Intestinal Obstruction
3
2021
49
1.540
 Why?
Gastroenterology
6
2024
177
1.410
 Why?
Immunosuppressive Agents
6
2020
858
1.310
 Why?
Tissue Adhesions
3
2021
30
1.310
 Why?
Tumor Necrosis Factor-alpha
10
2023
1205
1.150
 Why?
Adrenal Cortex Hormones
4
2022
532
1.150
 Why?
Antibodies, Monoclonal, Humanized
4
2024
756
1.030
 Why?
Intestine, Small
2
2021
151
1.000
 Why?
Algorithms
6
2020
1617
0.940
 Why?
JC Virus
2
2015
23
0.910
 Why?
Leukoencephalopathy, Progressive Multifocal
2
2015
37
0.900
 Why?
Azathioprine
5
2021
50
0.840
 Why?
Bone Diseases, Metabolic
1
2023
57
0.830
 Why?
Abdomen
2
2021
119
0.790
 Why?
Esophageal Neoplasms
6
2022
297
0.790
 Why?
Abdominal Abscess
1
2022
26
0.780
 Why?
Biological Products
3
2023
207
0.780
 Why?
Humans
82
2025
129847
0.730
 Why?
Gastrointestinal Hemorrhage
3
2023
123
0.720
 Why?
Anti-Bacterial Agents
5
2018
1708
0.710
 Why?
Ustekinumab
1
2020
14
0.690
 Why?
Capsule Endoscopy
1
2020
18
0.680
 Why?
Antibodies, Viral
2
2015
602
0.680
 Why?
Biosimilar Pharmaceuticals
1
2020
20
0.670
 Why?
Biomedical Research
2
2019
640
0.660
 Why?
Barrett Esophagus
4
2023
148
0.650
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2021
430
0.610
 Why?
Quality-Adjusted Life Years
5
2021
106
0.610
 Why?
Colonoscopy
7
2024
237
0.600
 Why?
Intestinal Fistula
1
2018
15
0.580
 Why?
Surgical Procedures, Operative
1
2021
244
0.580
 Why?
Drug Utilization
1
2019
171
0.580
 Why?
Health Resources
1
2019
115
0.580
 Why?
Colonic Diseases
1
2018
32
0.580
 Why?
Pericardium
1
2018
54
0.570
 Why?
Tuberculin Test
1
2017
36
0.570
 Why?
Cost-Benefit Analysis
5
2021
569
0.570
 Why?
Models, Statistical
2
2019
624
0.560
 Why?
Mass Screening
4
2021
1192
0.550
 Why?
Epstein-Barr Virus Infections
1
2018
95
0.550
 Why?
Biological Factors
2
2023
36
0.550
 Why?
Retrospective Studies
22
2023
14553
0.550
 Why?
Postoperative Complications
2
2021
2481
0.540
 Why?
Time-to-Treatment
2
2019
179
0.540
 Why?
Latent Tuberculosis
1
2017
67
0.530
 Why?
Colorectal Neoplasms
6
2024
748
0.530
 Why?
Antibodies, Monoclonal
4
2021
1368
0.500
 Why?
Hospitalization
3
2022
2079
0.480
 Why?
Male
43
2025
63759
0.480
 Why?
Natalizumab
1
2015
40
0.470
 Why?
Middle Aged
33
2025
31177
0.470
 Why?
Heart Diseases
1
2018
352
0.450
 Why?
Adult
31
2025
35634
0.450
 Why?
Mycobacterium tuberculosis
1
2017
309
0.450
 Why?
Aged
27
2024
22107
0.440
 Why?
Models, Theoretical
1
2018
549
0.440
 Why?
Practice Patterns, Physicians'
3
2024
1274
0.440
 Why?
Severity of Illness Index
7
2024
2739
0.420
 Why?
Lymphoma
1
2014
198
0.410
 Why?
Markov Chains
3
2020
117
0.410
 Why?
Age Factors
4
2020
3161
0.410
 Why?
Spondylarthritis
2
2025
45
0.390
 Why?
Drug Therapy, Combination
4
2024
1042
0.390
 Why?
Adalimumab
3
2021
40
0.390
 Why?
Communicable Diseases
1
2014
152
0.380
 Why?
Female
39
2025
68829
0.380
 Why?
United Kingdom
5
2021
258
0.380
 Why?
Patient Discharge
2
2023
856
0.370
 Why?
Risk Factors
15
2022
9801
0.370
 Why?
Gastroenterologists
2
2022
18
0.360
 Why?
Professional Competence
1
2012
96
0.360
 Why?
Research Design
2
2019
1045
0.350
 Why?
Carcinoma, Squamous Cell
1
2016
628
0.350
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
340
0.340
 Why?
Research Personnel
1
2012
156
0.340
 Why?
Spondylitis, Ankylosing
2
2021
46
0.340
 Why?
Gastroesophageal Reflux
2
2023
232
0.340
 Why?
Adenoma
3
2024
213
0.340
 Why?
Colonic Polyps
2
2024
87
0.330
 Why?
Cohort Studies
9
2021
5444
0.320
 Why?
Proportional Hazards Models
5
2021
1199
0.320
 Why?
Urinary Bladder Neoplasms
3
2017
226
0.310
 Why?
Pediatric Obesity
1
2016
573
0.300
 Why?
United States
15
2025
13913
0.300
 Why?
Quality of Life
2
2021
2695
0.300
 Why?
Skin Neoplasms
1
2016
830
0.290
 Why?
Patient Acceptance of Health Care
3
2024
763
0.280
 Why?
Remission Induction
2
2024
274
0.270
 Why?
Electronic Health Records
5
2022
979
0.270
 Why?
Disease Management
2
2021
592
0.270
 Why?
Databases, Factual
7
2018
1269
0.270
 Why?
Mortality
2
2020
308
0.270
 Why?
Neoplasm Recurrence, Local
3
2017
957
0.260
 Why?
Referral and Consultation
2
2023
735
0.250
 Why?
Population Surveillance
2
2021
439
0.250
 Why?
Aged, 80 and over
10
2020
7066
0.240
 Why?
Antifungal Agents
2
2016
130
0.240
 Why?
Treatment Outcome
10
2024
10241
0.230
 Why?
Case-Control Studies
8
2021
3384
0.230
 Why?
Recurrence
5
2021
1013
0.230
 Why?
Delivery of Health Care
2
2021
900
0.220
 Why?
Esophageal Stenosis
2
2014
51
0.220
 Why?
Gastrointestinal Microbiome
2
2022
641
0.220
 Why?
Adenocarcinoma
2
2021
893
0.210
 Why?
Obesity
1
2017
2885
0.210
 Why?
Incidence
7
2021
2646
0.210
 Why?
Diagnosis, Computer-Assisted
1
2024
86
0.210
 Why?
Colectomy
2
2021
93
0.210
 Why?
Esophagitis, Peptic
1
2023
15
0.200
 Why?
Protective Factors
2
2021
91
0.200
 Why?
Models, Economic
2
2020
53
0.200
 Why?
Absorptiometry, Photon
1
2023
247
0.200
 Why?
Glucocorticoids
2
2018
582
0.200
 Why?
Surveys and Questionnaires
7
2025
5437
0.200
 Why?
Comparative Effectiveness Research
2
2024
151
0.190
 Why?
Cellulitis
1
2022
49
0.190
 Why?
Medical Marijuana
1
2024
111
0.190
 Why?
Odds Ratio
4
2018
1022
0.190
 Why?
Insurance, Health
1
2024
269
0.190
 Why?
Pancreatic Neoplasms
2
2021
879
0.180
 Why?
Necrosis
1
2022
234
0.180
 Why?
Rectal Fistula
1
2021
21
0.180
 Why?
Prognosis
3
2019
3773
0.180
 Why?
Logistic Models
5
2018
1989
0.180
 Why?
Artificial Intelligence
1
2024
245
0.180
 Why?
Aftercare
1
2023
206
0.180
 Why?
Liver Transplantation
2
2021
833
0.180
 Why?
Feces
2
2022
442
0.180
 Why?
Gynecologic Surgical Procedures
1
2021
57
0.170
 Why?
Esophagoscopy
2
2022
198
0.170
 Why?
Leukocyte L1 Antigen Complex
1
2020
30
0.170
 Why?
Cystectomy
2
2017
38
0.170
 Why?
Utilization Review
1
2020
36
0.170
 Why?
Digestive System Surgical Procedures
1
2021
98
0.170
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2020
33
0.160
 Why?
Bone Density
1
2023
463
0.160
 Why?
Carcinoma
1
2021
213
0.160
 Why?
Diabetes Mellitus
2
2021
1003
0.160
 Why?
Urologic Surgical Procedures
1
2021
113
0.160
 Why?
Metagenomics
1
2021
156
0.160
 Why?
Tryptophan
1
2021
177
0.160
 Why?
Quality Assurance, Health Care
1
2021
318
0.160
 Why?
Sensitivity and Specificity
1
2024
1847
0.160
 Why?
Hospitals
2
2021
649
0.160
 Why?
Deglutition Disorders
1
2021
133
0.160
 Why?
Obesity, Morbid
1
2023
242
0.160
 Why?
Hospitals, Veterans
1
2020
242
0.150
 Why?
Chronic Disease
2
2022
1724
0.150
 Why?
Metabolomics
2
2022
652
0.150
 Why?
Follow-Up Studies
3
2019
4896
0.150
 Why?
Job Satisfaction
1
2021
204
0.150
 Why?
Health Care Costs
1
2021
367
0.150
 Why?
Diverticulum
1
2018
11
0.150
 Why?
Carcinoma, Pancreatic Ductal
1
2021
269
0.150
 Why?
Hematemesis
1
2018
3
0.150
 Why?
Symptom Assessment
2
2017
125
0.140
 Why?
Vascular Surgical Procedures
1
2021
295
0.140
 Why?
Prevalence
3
2021
2564
0.140
 Why?
Intestines
1
2021
350
0.140
 Why?
Clostridium Infections
1
2018
64
0.140
 Why?
Endoscopic Mucosal Resection
1
2017
24
0.140
 Why?
Arthritis, Rheumatoid
2
2016
1098
0.140
 Why?
Fatal Outcome
1
2018
300
0.140
 Why?
Risk Assessment
3
2016
3269
0.130
 Why?
Randomized Controlled Trials as Topic
2
2024
1368
0.130
 Why?
Cystadenoma, Mucinous
1
2016
13
0.130
 Why?
Continuity of Patient Care
1
2019
277
0.130
 Why?
Analgesics, Opioid
1
2024
925
0.130
 Why?
Itraconazole
1
2016
6
0.130
 Why?
Budesonide
1
2016
89
0.130
 Why?
Child
5
2023
20962
0.130
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2016
54
0.130
 Why?
Pharmacoepidemiology
1
2015
20
0.130
 Why?
Endoscopy, Gastrointestinal
3
2023
219
0.120
 Why?
Guideline Adherence
1
2020
527
0.120
 Why?
Pancreatic Diseases
1
2016
71
0.120
 Why?
Cysts
1
2016
108
0.120
 Why?
Societies, Medical
3
2024
759
0.120
 Why?
Neoplasms, Second Primary
1
2016
106
0.120
 Why?
Hyperlipidemias
1
2016
127
0.120
 Why?
Neoplasms
2
2023
2454
0.120
 Why?
Antirheumatic Agents
1
2018
280
0.120
 Why?
Data Accuracy
1
2015
58
0.120
 Why?
Psoriasis
1
2016
87
0.120
 Why?
Polypharmacy
1
2015
84
0.120
 Why?
Arthritis, Juvenile
1
2015
53
0.120
 Why?
Hedgehog Proteins
1
2016
188
0.110
 Why?
Burnout, Professional
1
2021
411
0.110
 Why?
Interferon-gamma
1
2017
773
0.110
 Why?
Dilatation
1
2014
61
0.110
 Why?
Prescription Drugs
1
2015
112
0.110
 Why?
Cholesterol
1
2016
412
0.110
 Why?
Microbiota
1
2022
734
0.110
 Why?
Immunologic Factors
1
2016
229
0.110
 Why?
Anastomosis, Surgical
1
2014
150
0.110
 Why?
Streptococcal Infections
1
2016
148
0.110
 Why?
Renal Insufficiency, Chronic
1
2019
567
0.110
 Why?
Virus Diseases
1
2016
210
0.100
 Why?
Radiation Injuries
1
2014
135
0.100
 Why?
Early Detection of Cancer
3
2022
371
0.100
 Why?
Registries
1
2021
1903
0.100
 Why?
Disease Progression
2
2021
2628
0.100
 Why?
Young Adult
6
2019
12467
0.100
 Why?
Foreign Bodies
1
2014
103
0.100
 Why?
Cross-Sectional Studies
3
2025
5085
0.100
 Why?
Primary Health Care
2
2022
1687
0.100
 Why?
Epidemiology
1
2012
15
0.100
 Why?
Diabetes Complications
1
2013
224
0.090
 Why?
Tissue and Organ Procurement
1
2015
290
0.090
 Why?
Endoscopy
1
2014
290
0.090
 Why?
Biomarkers
2
2020
3971
0.090
 Why?
Research Support as Topic
1
2012
112
0.090
 Why?
Age Distribution
1
2012
372
0.090
 Why?
Predictive Value of Tests
1
2016
1951
0.090
 Why?
Adolescent
6
2019
20451
0.090
 Why?
Physicians
1
2019
875
0.090
 Why?
Veterans
1
2021
1383
0.080
 Why?
Infant
4
2016
9018
0.080
 Why?
Child, Preschool
4
2016
10522
0.080
 Why?
Prospective Studies
4
2024
7158
0.080
 Why?
Medicare
3
2021
719
0.080
 Why?
Drug Prescriptions
2
2024
249
0.070
 Why?
Emergency Service, Hospital
1
2019
1920
0.070
 Why?
Laparoscopy
1
2012
447
0.070
 Why?
Neoplasm Staging
2
2022
1282
0.070
 Why?
Kaplan-Meier Estimate
2
2020
851
0.060
 Why?
Network Meta-Analysis
1
2024
9
0.060
 Why?
Janus Kinase Inhibitors
1
2024
26
0.060
 Why?
Breast Neoplasms
1
2016
2104
0.060
 Why?
Survival Analysis
2
2017
1271
0.050
 Why?
Regression Analysis
2
2017
998
0.050
 Why?
Time Factors
3
2019
6550
0.050
 Why?
Piperidines
1
2024
200
0.050
 Why?
Insurance Coverage
1
2024
220
0.050
 Why?
Gastrectomy
1
2023
102
0.050
 Why?
Consensus
1
2024
622
0.050
 Why?
Cost Savings
1
2021
78
0.050
 Why?
Granzymes
1
2021
47
0.040
 Why?
Documentation
1
2023
185
0.040
 Why?
Training Support
1
2021
28
0.040
 Why?
Salaries and Fringe Benefits
1
2021
56
0.040
 Why?
Evidence-Based Medicine
1
2024
716
0.040
 Why?
Morbidity
1
2021
302
0.040
 Why?
Metabolic Networks and Pathways
1
2021
177
0.040
 Why?
Perception
1
2022
347
0.040
 Why?
Reproducibility of Results
2
2019
3089
0.040
 Why?
SEER Program
1
2020
202
0.040
 Why?
Dysbiosis
1
2021
170
0.040
 Why?
Disease Susceptibility
1
2021
334
0.040
 Why?
Medicine
1
2021
119
0.040
 Why?
Physician's Role
1
2021
206
0.040
 Why?
Age of Onset
1
2020
494
0.040
 Why?
Career Choice
1
2021
206
0.040
 Why?
Delayed Diagnosis
1
2019
79
0.040
 Why?
Pharmacovigilance
1
2018
21
0.040
 Why?
Gene Expression Regulation, Bacterial
1
2021
324
0.040
 Why?
Mathematical Concepts
1
2018
26
0.040
 Why?
Decision Support Systems, Clinical
1
2021
206
0.040
 Why?
Academic Medical Centers
1
2021
483
0.040
 Why?
Margins of Excision
1
2017
38
0.030
 Why?
Clinical Competence
1
2024
1020
0.030
 Why?
Prednisone
1
2018
234
0.030
 Why?
Mercaptopurine
1
2016
15
0.030
 Why?
Pilot Projects
1
2022
1597
0.030
 Why?
Longitudinal Studies
1
2024
2724
0.030
 Why?
Hip Fractures
1
2018
83
0.030
 Why?
Etanercept
1
2016
56
0.030
 Why?
Computational Biology
1
2021
594
0.030
 Why?
Survival Rate
1
2021
1872
0.030
 Why?
Decision Making
1
2023
864
0.030
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2016
55
0.030
 Why?
Glomerular Filtration Rate
1
2019
711
0.030
 Why?
Cause of Death
1
2018
395
0.030
 Why?
Streptococcus pyogenes
1
2016
39
0.030
 Why?
Intestinal Mucosa
1
2021
593
0.030
 Why?
Weight Loss
1
2021
740
0.030
 Why?
Methotrexate
1
2016
249
0.030
 Why?
Bias
1
2016
197
0.030
 Why?
Statistics, Nonparametric
1
2015
422
0.030
 Why?
Pennsylvania
1
2014
108
0.030
 Why?
Neoplasm Invasiveness
1
2016
484
0.030
 Why?
Mental Recall
1
2015
191
0.030
 Why?
Gene Expression Profiling
1
2021
1686
0.030
 Why?
Computer Simulation
1
2018
941
0.030
 Why?
Waiting Lists
1
2015
238
0.030
 Why?
Anticoagulants
1
2018
637
0.030
 Why?
Medicaid
1
2018
433
0.030
 Why?
Practice Guidelines as Topic
1
2021
1514
0.030
 Why?
T-Lymphocytes
1
2021
1937
0.030
 Why?
Multivariate Analysis
1
2016
1501
0.020
 Why?
Respiratory Tract Infections
1
2015
376
0.020
 Why?
Sex Factors
1
2015
1973
0.020
 Why?
Cardiovascular Diseases
1
2018
2008
0.020
 Why?
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (298) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)